Global COVID-19 Antibody Detection Kits Competitive Landscape Professional Research Report 2025

Research Summary

COVID-19 antibody detection kits are medical diagnostic tools designed to identify the presence of antibodies in a person＇s blood that are specific to the SARS-CoV-2 virus, which causes COVID-19. These kits typically use a small blood sample, obtained through a finger prick or venous draw, and analyze it to detect the presence of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies produced by the body in response to the virus. IgM antibodies are usually the first to appear after infection, while IgG antibodies develop later and provide long-term immunity. COVID-19 antibody detection kits are essential for determining past infections, assessing potential immunity in individuals, and studying the prevalence of the disease in populations. However, it is important to note that these kits should not be used for diagnosing current or acute infections, as it takes some time for the body to develop detectable levels of antibodies after exposure to the virus. Therefore, they are primarily used for serological studies, surveillance, and research purposes rather than as a standalone diagnostic tool for active infections.

According to DIResearch's in-depth investigation and research, the global COVID-19 Antibody Detection Kits market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of COVID-19 Antibody Detection Kits include Cellex, Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics, Mount Sinai Laboratory, Ortho Clinical Diagnostics, Zhejiang Orient Gene Biotech, Innovita Biological Technology, Guangzhou Wondfo Biotech, Guangdong Hecin-Scientific, ADVAITE, Dynamiker Biotechnology （Tianjin） etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of COVID-19 Antibody Detection Kits. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global COVID-19 Antibody Detection Kits market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the COVID-19 Antibody Detection Kits market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of COVID-19 Antibody Detection Kits industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of COVID-19 Antibody Detection Kits Include:

Cellex

Abbott

Roche

BioMedomics

BD

Henry Schein

Safecare Bio-Tech

Mayo Clinic Laboratories

Chembio Diagnostics

Mount Sinai Laboratory

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Innovita Biological Technology

Guangzhou Wondfo Biotech

Guangdong Hecin-Scientific

ADVAITE

Dynamiker Biotechnology （Tianjin）

COVID-19 Antibody Detection Kits Product Segment Include:

Rapid Diagnostic Test (RDT)

Enzyme Linked Immunosorbent Assay (ELISA)

Neutralization Assay

COVID-19 Antibody Detection Kits Product Application Include:

Hospitals

Scientific Research

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global COVID-19 Antibody Detection Kits Industry PESTEL Analysis

Chapter 3: Global COVID-19 Antibody Detection Kits Industry Porter’s Five Forces Analysis

Chapter 4: Global COVID-19 Antibody Detection Kits Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global COVID-19 Antibody Detection Kits Market Size and Forecast by Type and Application Analysis

Chapter 6: North America COVID-19 Antibody Detection Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe COVID-19 Antibody Detection Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China COVID-19 Antibody Detection Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) COVID-19 Antibody Detection Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America COVID-19 Antibody Detection Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa COVID-19 Antibody Detection Kits Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global COVID-19 Antibody Detection Kits Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources